Author
davin
View
85
Download
0
Tags:
Embed Size (px)
DESCRIPTION
Introduction - Toxoplasma gondii. Obligate intracellular parasite Infects a wide range of avian and mammalian species Host: cat; can be carried by mammals and birds Can cause severe disease in humans Toxoplasmosis can have fatal effects on a fetus - PowerPoint PPT Presentation
Introduction - Toxoplasma gondii
• Obligate intracellular parasite
• Infects a wide range of avian and mammalian species
• Host: cat; can be carried by mammals and birds
• Can cause severe disease in humans
• Toxoplasmosis can have fatal effects on a fetus
• T. gondii can exist as either rapidly growing tachyzoites or bradyzoites that reside in semidormant cysts
Introduction - Toxoplasma gondii
• NK cells, CD4+ T cells and CD8+ T cells produce cytokines against T. gondii
• CD8+ T cells are known to have a critical protective function
• Resistance to toxoplasmic encephalitis in H-2d mice has been linked to the locus encoding H-2Ld MHC class I
• The mechanisms and antigens that elicit the activation and expansion of T. gondii–specific CD8+ T cell populations are not understood
Introduction - Antigen processing
• CD8+ T cells recognize intracellular protein derived peptides presented by MHC class I
• Antigenic peptides: proteolysis in the cytoplasm, transport into the ER, further processing by the aminopeptidase ERAAP
• ERAAP is very important for shaping of peptides for MHC class I
Clinical and Experimental Immunology 2005
TCR: T cell receptor; TAP: transporter associated with antigen processing; ERAAP: endoplasmic reticulum aminopeptidase associated with antigen processing
Questions
What are the natural antigens for MHC class I
presentation and how are they processed?
Infection of ERAAP-deficient mice
• i.p. infection of resistant H-2d mice (B10.D2) with T. gondii tachyzoites– ERAAP deficient– ERAAP-heterozygous– wild-type
Tachyzoites: rapidly growing T. gondii; ERAAP: endoplasmic reticulum aminopeptidase associated with antigen processing
ERAAP-deficient mice are susceptible to T. gondii
Survival was significantly impaired in the absence of ERAAP
ERAAP: endoplasmic reticulum aminopeptidase associated with antigen processing
– heterozygous/wt– deficient
Flow cytometry
PCR
T. gondii hybridomas
Tachyzoites: rapidly growing T. gondii
• Immunization of resistant BALB/c (H-2d) mice with γ-irradiated tachyzoites
• CD8+ T cells and CD4+ T cells produced IFN-γ
• Expansion of the T. gondii–specific CD8+ T cell populations by restimulation in vitro
T. gondii hybridomas
• Hybridoma were created by fusion of the T. gondii–specific CD8+ T cells and a TCR αβ-negative fusion partner with inducible β-galactosidase
• Occupancy of the TCR can be assayed by measurement of intracellular lacZ activity
• T. gondii infection of APCs expressing H-2Ld or H-2Kd MHC class I molecules
T. gondii hybridomas
Response of the hybridomas to T. gondii infected APCs expressing H-2Ld but not to those expressing H-2Kd MHC class I molecules
H-2Ld and a T. gondii-derived peptide is necessary for hybridoma activation
Identification of the natural T. gondii antigen GRA6
GRA6: dense granule protein 6; secreted by T. gondii
• Preparation of a plasmid cDNA library with mRNA from T. gondii tachyzoites
• Transfection of H-2Ld fibroblasts with cDNA
• Incubation with CTgEZ.4 T cell hybridomas
• The five most positive had 100% identity to the dense granule protein 6 (GRA6)
Hybridoma stimulation• Transfection of H-2Ld fibroblasts with full-length GRA6 cDNA or a c-
terminal deletion construct
• Incubation with hybridoma
GRA6: dense granule protein 6; secreted by T. gondii
CTgEZ.4 hybridoma were stimulated with full-length but not with mutated GRA6
the antigenic epitope was located in the deleted residues
Hybridomas recognizethe HF10 decapeptide
• Systematically testing of all potential peptides
the decapeptide HPGSVNEFDF (HF10) was recognized by the hybridoma
Fractation by HPLC
BMDM: bone marrow–derived macrophages; BMDC: bone marrow–derived dendritic cellsHPLC: high-performance liquid chromatography; GRA6: dense granule protein 6
• Fractation of synthetic HF10 analogs by HPLC
• Testing of all fractions for hybridoma activation
Fractation by HPLC
BMDM: bone marrow–derived macrophages; BMDC: bone marrow–derived dendritic cellsHPLC: high-performance liquid chromatography; GRA6: dense granule protein 6
• Fractation of extracts of GRA6-transfected H-2Ld L fibroblasts and T. gondii–infected BMDMs and BMDCs by HPLC
• Testing of all fractions for hybridoma activation
HF10 was the naturally processed product of the GRA6 protein presented by H-2Ld
Monitoring of CD8+ T cells
• Orally infection of mice with T. gondii cysts
• Incubation of spleen and brain cells with H-2Ld MHC multimers (DimerX) loaded with HF10 or QL9 4 weeks after infection
• Staining with PE-coupled α–mouse IgG1
Monitoring of CD8+ T cells
• 5% of splenic CD8+ T cells • 24% of CD8+ brain T cells• Only for HF10 but not QL9 HF10–H-2Ld was a naturally processed ligand
recognized by CD8+ T cells during T. gondii infection.
Monitoring of CD8+ T cells
• Speceficity of CD8+ T cells for HF10–H-2Ld was unexpected because the T. gondii genome contains over 8,000 proteinencoding genes
• Assesment of the relative frequency of CD8+ T cells specific for HF10 versus other potential antigens among all IFN-γ-producing CD8+ T cells elicited by T. gondii
Monitoring of CD8+ cells
• i.p. infection of mice with T. gondii tachyzoites
• Splenic CD8+ T cells were stimulated with T. gondii-infected J774 macrophages 4 weeks after infection
• 18% produced IFNγ
Monitoring of CD8+ T cells
• i.p. infection of mice with T. gondii tachyzoites
• Stimulation of the CD8+ T cells with J774 macrophages loaded with the HF10 peptide
• 20% produced IFNγ
GRA6-derived HF10 is an immunodominant T. gondii antigen in H-2d mice
Immunization with HF10
BMDC: bone marrow–derived dendritic cells
• Immunization of B10.D2 H-2d mice with BMDCs pulsed with HF10 or YL9
all control mice succumbed to infection within 12 d all HF10-immunized mice survived
Immunization with HF10
BMDC: bone marrow–derived dendritic cells
• Immunization of C57BL/6 H-2b mice with BMDCs pulsed with HF10 or YL9
no protection from T. gondii protection from disease was MHC restricted
Immunization with HF10
BMDC: bone marrow–derived dendritic cells
• Depletion of CD8+ cells of B10.D2 H-2d mice • Immunization with BMDCs pulsed with HF10 or YL9• Infection of splenocytes and peritoneal cells with T. gondii (GFP+)
CD8+ cells were critical for protection HF10 was able to elicit a protective CD8+ T cell response during T.
gondii infection in H-2d mice
Processing and generation of HF10–H-2Ld complexes
Processing and generation of HF10–H-2Ld complexes
BMDM: bone marrow–derived macrophages
• Treatment of T. gondii infected BMDMs with the proteasome inhibitors epoxomicin or lactacystin
• Incubation with hybridoma
lower CTgEZ.4 hybridoma activation with inhibitor treatment Proteasomes were required for the generation of HF10–H-2Ld complexes.
Processing and generation of HF10–H-2Ld complexes
BMDM: bone marrow–derived macrophages
• Transduction of H-2Ld into TAP-deficient or wild-type C57BL/6 BMDMs
• Infection with T. gondii
TAP-deficient BMDMs failed to stimulate the CTgEZ.4 hybdroma TAP transport was essential for presentation of the HF10–H-2Ld complex
Processing and generation of HF10–H-2Ld complexes
BMDM: bone marrow–derived macrophages; BMDC: bone marrow–derived dendritic cells
• Infection of ERAAP-heterozygous or ERAAP-deficient BMDMs or BMDCs with T. gondii
• Incubation with the CTgEZ.4 hybridoma
cells from ERAAP-deficient mice were not able to activate the hybridoma
Processing and generation of HF10–H-2Ld complexes
BMDM: bone marrow–derived macrophages; BMDC: bone marrow–derived dendritic cells
• Incubation of ERAAP-heterozygous or ERAAP-deficient BMDMs or BMDCs presenting HF10 with the hybridoma
• Incubation with the CTgEZ.4 hybridoma
no differences in ERAAP-heterozygous or ERAAP-deficient cells for hybridoma activation
Processing and generation of HF10–H-2Ld complexes
BMDM: bone marrow–derived macrophages
• Extraction of naturally processed peptides from ERAAP-deficient and ERAAP-heterozygous infected BMDMs
two peaks of antigenic activity– fraction 34 could serve as precursors of HF10– fraction 32 was barely detected in extracts of ERAAP-deficient
cells
Processing and generation of HF10–H-2Ld complexes
• Measurement of the T. gondii–induced CD8+ T cell responses of ERAAP-deficient mice
less HF10-specific CD8+ T cells in ERAAP-deficient mice than in ERAAP-heterozygous mice
ERAAP-deficient APCs can`t generate the HF10–H-2Ld complexes and can`t elicit HF10-specific CD8+ T cell response
Summary
• ERAAP-deficient mice are susceptible to T. gondii
• GRA6 is the natural T. gondii antigen
• HF10 is the naturally processed product of the GRA6 protein presented by H-2Ld
• Successfull immunization of mice with HF10 against T. gondii
• Protection from disease was MHC restricted
• ERAAP-deficient APCs can`t generate the HF10–H-2Ld complexes and can`t elicit HF10-specific CD8+ T cell response
Thank you for your attention